Observation on the Effects of Intraosseous Access on Inflammatory Mediators, Hematopoietic Cell Function, and Coagulation-Metabolic Disturbances in Emergency Traumatic Hemorrhagic Shock Patients
Abstract
Objective: This study aimed to evaluate the impact of intraosseous (IO) access on inflammatory mediators, hematopoietic cell function, and coagulation-metabolic disturbances in patients presenting with emergency traumatic hemorrhagic shock (THS), thereby providing clinical evidence to refine IO resuscitation protocols in emergency settings.
Methods: We conducted a randomized controlled trial involving 84 THS patients admitted between February 2024 and February 2025. Participants were allocated equally into two groups: the IO group (n=42), where vascular access was established via humeral or proximal tibial puncture, and the intravenous (IV) group (n=42), where conventional peripheral or central venous access was prioritized. Serial measurements were performed at baseline (T0), 24 hours (T1), and 72 hours (T2) post-intervention to assess: (1) inflammatory mediators (IL-1β, IL-6, IL-10, HMGB1, MDA); (2) hematopoietic parameters (CD34+ cell proportion, CFU-GM/BFU-E colony formation, CXCL12, EPO, and TPO); (3) coagulation profiles (PT, APTT, and D-dimer); and (4) tissue perfusion indicators (blood lactate and lactate clearance rate). Comparative analyses were conducted both between groups and across different time points.
Results: The IO group demonstrated significantly elevated levels of IL-1β, HMGB1, and MDA at T1 and T2 compared to the IV group (P<0.05), coupled with reduced IL-10 expression (P<0.05), indicating exacerbated inflammatory imbalance and oxidative stress. Hematopoietic evaluation revealed progressive declines in CD34+ cell populations, CFU-GM/BFU-E colony formation, and CXCL12 concentration in the IO group at T1 and T2 (P<0.05), despite modest compensatory increases in EPO and TPO that remained inferior to the IV group (P<0.05). Coagulation studies showed prolonged PT/APTT (P<0.01) and higher D-dimer levels (P<0.05) in the IO group, along with worse blood lactate levels and lactate clearance rates compared to the IV group (P<0.05), suggesting increased tissue hypoxia and coagulopathy risk.
Conclusion: While IO access enables rapid vascular access for resuscitation and reduces critical intervention time, our findings demonstrate that it may inadvertently aggravate systemic inflammatory dysregulation, impair hematopoietic function, and worsen coagulation-metabolic disturbances through mechanisms such as mechanical stimulation, hypothermic fluid infusion, and oxidative stress.
Copyright (c) 2025 Gaorong Deng, Lang Jiang, Xin Miao, Yuying Dong, Xiang Gao, Zongfang Li
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.